---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-136025"
form_type: "8-K"
ticker: "DBVT"
cik: "0001613780"
company_name: "DBV Technologies S.A."
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T22:06:36.728604+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# DBV Technologies Q1 net loss widens to $20.5M; cash drops to $192.3M

## Summary
- Cash and equivalents $192.3M as of March 31, 2023, down from $209.2M at Dec 31, 2022.
- Net loss of $20.5M for Q1 2023 vs $16.7M loss in Q1 2022; loss per share $0.22.
- R&D expenses rose 31% to $16.0M, driven by initiation of VITESSE trial in March 2023.
- Cash used in operations $20.8M vs $1.5M in Q1 2022; prior year included $20.9M French R&D tax credit receipt.
- Total operating expenses $23.3M, up 21% from $19.3M in Q1 2022.

## SEC filing metadata
- accession: 0001193125-23-136025
- form_type: 8-K
- ticker: DBVT
- cik: 0001613780
- company_name: DBV Technologies S.A.
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613780/000119312523136025/0001193125-23-136025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613780/000119312523136025/d298404d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-136025
- JSON: https://secwatch.observer/filing/0001193125-23-136025.json
- Plain text: https://secwatch.observer/filing/0001193125-23-136025.txt

## Key facts
- Earnings Releases
  DBV Technologies S.A. reported the fiscal quarter ended March 31, 2023 results: revenue 2.2, net income Net result for the three months ended March 31, 2023 is a loss amounting to $20.5 million, EPS $0.22 for the three months ended March 31, 2023.
  - Period: the fiscal quarter ended March 31, 2023
  - Revenue: 2.2
  - Net income: Net result for the three months ended March 31, 2023 is a loss amounting to $20.5 million
  - EPS: $0.22 for the three months ended March 31, 2023
  - Result: reported results
  source text: Income In millions of USD Three months ended March 31, 2023 2022 Variation Research tax credits 1.8 1.5 +0.3 +20% Other operating income 0.4 1.0 -0.6 -60% Operating income 2.2 2.5 -0.3 -12% Operating income amounts to $2.2 million as of March 31, 2023, compared to $2.5 million as of March 31, 2022, which is a decrease of $0.3 million due to: (1) $0.3
  evidence_url: https://www.sec.gov/Archives/edgar/data/1613780/000119312523136025/0001193125-23-136025-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.